07 March 2025
07 March 2025
Funding for women’s health remains disproportionately low, despite its significant economic potential.
This clearance represents the company’s second FDA clearance for a QIAstat-Dx panel this year.
Named after the Netherlands’ first female doctor, Aletta Jacobs, the device is claimed to “optimise” blood draws.
Scientists have successfully demonstrated the chip mediates drug efficacy tests on cancer models.
The company aims to 'reimagine' the use and management of medical records in the healthcare industry.
Cerus states that the CE mark represents the first regulatory approval for its “next generation” illuminator.
The proceeds will mainly support the ATLAS trial, currently underway in Europe and the US.
Baxter is recalling certain Spectrum infusion pumps due to missing motor mounting screws.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
